Roy R. Teller

Array ( [id] => 5350173 [patent_doc_number] => 20090005534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Methods and Compositions for the Treatment of Gastrointestinal Disorders' [patent_app_type] => utility [patent_app_number] => 11/930696 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22392 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005534.pdf [firstpage_image] =>[orig_patent_app_number] => 11930696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290905 [patent_doc_number] => 20090023635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Factor VII or VIIa - Like Molecules' [patent_app_type] => utility [patent_app_number] => 11/928108 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29161 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023635.pdf [firstpage_image] =>[orig_patent_app_number] => 11928108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4964794 [patent_doc_number] => 20080107614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'PEPTIDE-BASED CONDITIONERS' [patent_app_type] => utility [patent_app_number] => 11/923829 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21551 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107614.pdf [firstpage_image] =>[orig_patent_app_number] => 11923829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894191 [patent_doc_number] => 20080103290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Process for purifying glycopertide phosphonate derivatives' [patent_app_type] => utility [patent_app_number] => 11/977605 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15092 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103290.pdf [firstpage_image] =>[orig_patent_app_number] => 11977605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682798 [patent_doc_number] => 20080249024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Peptides facilitating or inhibiting a nterograde transport' [patent_app_type] => utility [patent_app_number] => 11/975388 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9025 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249024.pdf [firstpage_image] =>[orig_patent_app_number] => 11975388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9441068 [patent_doc_number] => 08710178 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'Macrocyclic cysteine protease inhibitors and compositions thereof' [patent_app_type] => utility [patent_app_number] => 12/446053 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 40085 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12446053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713272 [patent_doc_number] => 08399412 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating NF-kappabeta or supressing NF-kappabeta-mediated actions' [patent_app_type] => utility [patent_app_number] => 12/444331 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 9447 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12444331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441048 [patent_doc_number] => 20090092687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Prhormone composition and method of use thereof' [patent_app_type] => utility [patent_app_number] => 11/906958 [patent_app_country] => US [patent_app_date] => 2007-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6840 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092687.pdf [firstpage_image] =>[orig_patent_app_number] => 11906958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6630108 [patent_doc_number] => 20100004316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'MULTIFUNCTIONAL CARRIERS FOR THE DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/443002 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 19116 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004316.pdf [firstpage_image] =>[orig_patent_app_number] => 12443002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4726746 [patent_doc_number] => 20080206287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Use of cyclosporin A to sensitize resistant cancer cells to death receptor ligands' [patent_app_type] => utility [patent_app_number] => 11/901582 [patent_app_country] => US [patent_app_date] => 2007-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16729 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206287.pdf [firstpage_image] =>[orig_patent_app_number] => 11901582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328829 [patent_doc_number] => 08236926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Rapid glycopeptide optimization via neoglycosylation' [patent_app_type] => utility [patent_app_number] => 11/850877 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 10943 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11850877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421774 [patent_doc_number] => 08278263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase D and raptor' [patent_app_type] => utility [patent_app_number] => 12/374262 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 8357 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12374262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5522276 [patent_doc_number] => 20090030257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Anti-microbial photodynamic therapy' [patent_app_type] => utility [patent_app_number] => 11/880974 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3445 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20090030257.pdf [firstpage_image] =>[orig_patent_app_number] => 11880974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4604755 [patent_doc_number] => 07985735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-26 [patent_title] => 'Dimeric IAP inhibitors' [patent_app_type] => utility [patent_app_number] => 11/782360 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19785 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/985/07985735.pdf [firstpage_image] =>[orig_patent_app_number] => 11782360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577331 [patent_doc_number] => 08343539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Compounds that bind α5β1 integrin and methods of use' [patent_app_type] => utility [patent_app_number] => 12/373775 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 23667 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12373775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4909250 [patent_doc_number] => 20080020016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Pharmaceutical compositions for sustained release delivery of peptides' [patent_app_type] => utility [patent_app_number] => 11/827260 [patent_app_country] => US [patent_app_date] => 2007-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8076 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20080020016.pdf [firstpage_image] =>[orig_patent_app_number] => 11827260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4734368 [patent_doc_number] => 20080051348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'TREATMENT OF INFECTIONS AND OTHER DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/773168 [patent_app_country] => US [patent_app_date] => 2007-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4245 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051348.pdf [firstpage_image] =>[orig_patent_app_number] => 11773168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500910 [patent_doc_number] => 20100215699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'LACTOFERRIN AS A RADIOPROTECTIVE AGENT' [patent_app_type] => utility [patent_app_number] => 12/305944 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12960 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215699.pdf [firstpage_image] =>[orig_patent_app_number] => 12305944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6201882 [patent_doc_number] => 20110064668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'J-SUPERFAMILY CONOTOXIN PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/301827 [patent_app_country] => US [patent_app_date] => 2007-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20882 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064668.pdf [firstpage_image] =>[orig_patent_app_number] => 12301827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681762 [patent_doc_number] => 20080247988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'METHODS OF MAKING AND USING SURFACTANT POLYMERS' [patent_app_type] => utility [patent_app_number] => 11/751498 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8723 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20080247988.pdf [firstpage_image] =>[orig_patent_app_number] => 11751498 [rel_patent_id] =>[rel_patent_doc_number] =>)